Skip to main content
logo
Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
26.79
-0.96 (-3.46%)
Mar 24, 2026, 4:00 PM EDT - Market closed

Travere Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2,4713,4741,5236781,3521,940
Market Cap Growth
53.94%128.05%124.84%-49.89%-30.30%36.21%
Enterprise Value
2,4773,4741,480510.571,3051,645
Last Close Price
26.7938.2117.428.9921.0331.04
PE Ratio
--131.76-4.27-5.99-4.81-10.31
Forward PE
16.8838.08----
PS Ratio
5.047.086.534.6712.3514.71
PB Ratio
21.2130.2625.793.3731.556.42
P/TBV Ratio
20.8129.6923.263.3331.296.15
P/FCF Ratio
65.4091.95-6.42-2.42-7.26-97.51
P/OCF Ratio
65.4091.95-6.42-2.42-7.26-131.13
EV/Sales Ratio
5.057.086.353.5211.9212.48
EV/EBITDA Ratio
--1669.50-5.28-1.46-4.36-8.81
EV/EBIT Ratio
--55.30-4.57-1.32-4.08-8.25
EV/FCF Ratio
65.5691.95-6.23-1.82-7.00-82.69
Debt / Equity Ratio
2.812.815.541.999.410.85
Debt / EBITDA Ratio
-157.97-157.97-1.43-1.16-1.36-1.40
Debt / FCF Ratio
8.708.70-1.69-1.45-2.19-13.17
Net Debt / Equity Ratio
0.050.050.52-0.81-1.00-0.96
Net Debt / EBITDA Ratio
-2.85-2.85-0.110.460.141.56
Net Debt / FCF Ratio
0.160.16-0.130.580.2314.62
Asset Turnover
0.820.820.340.200.150.19
Inventory Turnover
0.310.310.230.640.750.51
Quick Ratio
2.522.521.983.313.284.58
Current Ratio
2.742.742.083.473.424.70
Return on Equity (ROE)
-57.88%-57.80%-246.75%-308.90%-192.18%-84.66%
Return on Assets (ROA)
-10.70%-10.69%-46.85%-53.15%-44.18%-28.87%
Return on Invested Capital (ROIC)
-52.29%-52.22%-369.68%-455.02%-263.76%-128.76%
Return on Capital Employed (ROCE)
-14.98%-14.98%-64.48%-68.01%-54.07%-34.17%
Earnings Yield
-1.03%-0.76%-23.42%-16.69%-20.78%-9.70%
FCF Yield
1.53%1.09%-15.59%-41.33%-13.78%-1.03%
Buyback Yield / Dilution
-1.08%-1.08%-9.29%-32.80%-2.00%-12.37%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q